title: Chronic oral administration of fenretinide, as a chemopreventive agent to breast cancer patients, does not affect plasma alpha-tocopherol concentration.
authors.forename: F
authors.initials: F
authors.lastname: Formelli
authors.forename: M
authors.initials: M
authors.lastname: Clerici
authors.forename: G
authors.initials: G
authors.lastname: De Palo
authors.forename: A
authors.initials: A
authors.lastname: Costa
authors.forename: U
authors.initials: U
authors.lastname: Veronesi
mesh_terms: D000284:Administration, Oral; D000328:Adult; D001943:Breast Neoplasms / Q000097:blood / Q000517:prevention & control*; D005260:Female; D017313:Fenretinide; D006801:Humans; D008875:Middle Aged; D016609:Neoplasms, Second Primary; D014212:Tretinoin / Q000008:administration & dosage / Q000031:analogs & derivatives*; D014810:Vitamin E / Q000097:blood
chemical_list: D014810:Vitamin E; D017313:Fenretinide; D014212:Tretinoin